Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
OPINION
Jim Cramer -- Avoid Caterpillar; own PayPal, Under Armour
By Bret Kenwell
Feb 22, 2016 2:07 PM EST
STOCKS
The Nominees for Best Biopharma CEO of 2015 Are...
By Adam Feuerstein
Dec 15, 2015 8:14 AM EST
INVESTING
A Biotech Believer; Does Manufacturing Still Matter?: Jim Cramer's Best Blogs
By Jim Cramer
Dec 4, 2015 9:00 PM EST
OPINION
Cramer: Ignore the Short-Term Noise, Stick With High-Quality Stocks
By Bret Kenwell
Sep 1, 2015 11:27 AM EDT
INVESTING
CELG, PFE, REGN, RCPT Jim Cramer's Views
By Jim Cramer
Aug 31, 2015 1:00 AM EDT
JIM CRAMER
Jim Cramer's 'Mad Money' Recap: Here's How Oil, the Fed and China Pushed Markets Up
By Scott Rutt
Aug 27, 2015 8:22 PM EDT
INVESTING
Bluebird, Pacira Pharmaceuticals Excite Life Science Investors
By Scott Gamm
Aug 12, 2015 5:42 PM EDT
VIDEO
Bluebird, Pacira Pharmaceuticals Gain Steam in Burgeoning Life Science Space
By Scott Gamm
Aug 12, 2015 5:00 PM EDT
STOCKS
Biotech Stock Mailbag: Controversial Stocks Revisited
By Adam Feuerstein
Aug 7, 2015 6:10 AM EDT
INVESTING
Bull Charts -- How'd We Do in July?
By Timothy Collins
Aug 6, 2015 2:15 PM EDT
STOCKS
Biogen's Possible Takeout Targets and Other Key Questions After Blow-Up
By Adam Feuerstein
Jul 27, 2015 10:30 AM EDT
INVESTING
FCX, CLF, BIIB, COF: Jim Cramer's Views
By Jim Cramer
Jul 27, 2015 1:00 AM EDT
OPINION
Jim cramer's top takeaways: celgene, facebook, amazon.com, netflix, google
By Scott Rutt
Jul 21, 2015 6:00 AM EDT
JIM CRAMER
Jim Cramer's 'Mad Money' Recap: Earnings Tsunami Heads Our Way
By Scott Rutt
Jul 20, 2015 8:31 PM EDT
INVESTING
NFLX, CELG, M, GS: Jim Cramer's Views
By Jim Cramer
Jul 20, 2015 1:00 AM EDT
INVESTING
Risks and Rewards; Oil Optimism; and the Winners Portfolio Managers Are Missing: Jim Cramer's Best Blogs
By Jim Cramer
Jul 17, 2015 9:00 PM EDT
INVESTING
Cramer Says Buy Celgene, Avoid AK Steel, Take FitBit Profits
By Jim Cramer
Jul 16, 2015 12:41 PM EDT
MARKETS
Celgene (CELG) Stock Continues to Climb Following Receptos Acquisition
By Tony Owusu
Jul 16, 2015 11:48 AM EDT
VIDEO
Cramer: AK Steel Is a Casualty of the Euro, Celgene Is Not a Sell
By Jim Cramer
Jul 16, 2015 11:42 AM EDT
JIM CRAMER
Jim Cramer's 'Mad Money' Recap: Take Notice of the Best Investors in the World
By Scott Rutt
Jul 15, 2015 8:27 PM EDT
MARKETS
Stocks End Winning Streak as Greek Protests Turn Violent
By Keris Alison Lahiff
Jul 15, 2015 4:02 PM EDT
MARKETS
Stocks Slip Into Red as Global Uncertainty Returns
By Keris Alison Lahiff
Jul 15, 2015 2:55 PM EDT
OPINION
3 Biotech Stocks to Trade Off the Receptos Buyout
By Jonas Elmerraji
Jul 15, 2015 1:56 PM EDT
VIDEO
Stocks Edge Higher as Yellen Speaks; Guess? Jumps on CEO Exit
By Keris Alison Lahiff
Jul 15, 2015 12:11 PM EDT
MARKETS
Stocks Edge Higher on Yellen Testimony; Crude Supplies Drop
By Keris Alison Lahiff
Jul 15, 2015 10:55 AM EDT